---
title: Evaluating a Mobile Self-management Application for Patients With COPD Chronic Obstructive Pulmonary Disease
nct_id: NCT04540562
overall_status: COMPLETED
phase: NA
sponsor: Rijnstate Hospital
study_type: INTERVENTIONAL
primary_condition: Chronic Obstructive Pulmonary Disease
countries: Netherlands
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT04540562.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT04540562"
ct_last_update_post_date: 2020-09-07
last_seen_at: "2026-05-12T07:00:29.113Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Evaluating a Mobile Self-management Application for Patients With COPD Chronic Obstructive Pulmonary Disease

**Official Title:** Evaluating the Feasibility of a Mobile Self-management Application for Patients With Chronic Obstructive Pulmonary Disease (COPD)

**NCT ID:** [NCT04540562](https://clinicaltrials.gov/study/NCT04540562)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 39
- **Lead Sponsor:** Rijnstate Hospital
- **Conditions:** Chronic Obstructive Pulmonary Disease
- **Start Date:** 2018-11-22
- **Completion Date:** 2020-04-25
- **CT.gov Last Update:** 2020-09-07

## Brief Summary

The objective of the study is to evaluate the effects of a mobile self-management app in clinical practice for recently discharged COPD patients on application use, self-management, anxiety and depression, expectations and experiences, patients' and health care professionals' satisfaction and hospital readmissions.

## Detailed Description

Usability testing techniques were used to receive feedback on a prototype of the app, before starting the feasibility study. Patients were recruited from a large teaching hospital. The COPD app provided patients with an 8 week self-management program. The application had three views: timeline, information page, and contact page. The start date was each patients' date of discharge. The timeline was classified in 8 weeks, and each week included the lung exacerbation plan, daily and extra medication, information and education and questionnaires. The first week also included a video of a pulmonologist explaining the purpose of the app and additional information about the functionalities of the COPD app. The timeline consisted of the lung exacerbation action plan, medication overview, weekly questionnaires and monitoring, and consultations (video consultation after 4 weeks and face-to-face consultation after 8 weeks).

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Age \> 18 Years
* Diagnosed with COPD
* Admissions to the hospital for exacerbation
* Having (access to) a tablet or smartphone
* Working internet connection
* Proficiency in using a tablet or smartphone
* Ability to read and understand the Dutch language
* Signed informed consent
* At least one hospitalization for COPD exacerbation in the year preceding the study (outcome was...)

Exclusion Criteria:

* No exacerbation of COPD
* Comorbidities: cancer, severe cognitive or psychiatric comorbidities
* No access to a tablet or smartpone
```

## Arms

- **Intervention** (EXPERIMENTAL) — The COPD app consisted of an 8 week self-management program. The app had three views: timeline, information page, and contact page. The timeline was classified in 8 weeks, and each week included the lung exacerbation plan, daily and extra medication, information and education and questionnaires. The first week also included a video of a pulmonologist explaining the purpose of the app and additional information about the functionalities of the COPD app. A video consultation was planned after after 4 weeks and a face-to-face consultation after 8 weeks.

## Interventions

- **COPD app** (OTHER) — The COPD app consisted of an 8 week self-management program. The app had three views: timeline, information page, and contact page. The timeline was classified in 8 weeks, and each week included the lung exacerbation plan, daily and extra medication, information and education and questionnaires. The first week also included a video of a pulmonologist explaining the purpose of the app and additional information about the functionalities of the COPD app. A video consultation was planned after after 4 weeks and a face-to-face consultation after 8 weeks.

## Primary Outcomes

- **Use (feasibility)** _(time frame: Week 1 through week 20)_ — Use based on log data: number of times the app was used per week.
- **Satisfaction (feasibility)** _(time frame: Week 8)_ — Questionnaires were used to assess satisfaction, information and user-friendliness of the app. The items were rated on a 7 point scale, varying from 1 (totally disagree) to 7 (totally agree). Overall satisfaction was rated on a scale from 1 (very unsatisfied) to 10 (very satisfied). Multiple response questions were used to assess if patients missed information in the app. Suggestions for improvement were asked using an open question. Yes/no questions were used to assess satisfaction with video consultation(s) (additional requested video consultations, problems and time saving).
- **Overall satisfaction (feasibility)** _(time frame: Week 20)_ — Overall satisfaction was rated on a scale varying from 1 (not satisfied) to 10 (very satisfied). Suggestion for improvement were assessed with an open question.

## Secondary Outcomes

- **Self-management - change over time** _(time frame: Baseline, week 8 and week 20)_
- **Expectations** _(time frame: Baseline)_
- **Experiences with technology** _(time frame: Week 8)_
- **Experiences with technology** _(time frame: Week 20)_
- **Anxiety - change over time** _(time frame: Week 1 until week 8)_
- **Depression - change over time** _(time frame: Week 1 and Week 8)_
- **Satisfaction nurses** _(time frame: After intervention completion, up to 15 months.)_
- **Hospital readmissions** _(time frame: 30 days)_
- **Hospital readmissions** _(time frame: 8 weeks)_
- **Hospital readmissions** _(time frame: 20 weeks)_
- **Use** _(time frame: Week 8)_
- **Use** _(time frame: Week 20)_

## Locations (1)

- Rijnstate, Arnhem, Netherlands

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.rijnstate|arnhem||netherlands` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT04540562.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT04540562*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*